Welcome to the Kantar Health Events Page RSS Feed Events

Connect with us at a healthcare industry or pharma event

Kantar Health Oncology Conference Insight Seminar - Italy

Kantar Health is hosting an Oncology Conference Insight seminar on 23 September 2014 in Milan, Italy, for pharmaceutical companies. The seminar will highlight the recent drug approvals and treatment trends, pricing and reimbursement implications, and clinical results on the oncology competitive landscape. The seminar will also offer an opportunity for a candid, mutual exchange of opinions and ideas. Additionally, we are incorporating qualitative input from community oncologists to further validate thoughts on the future of clinical development.


Richard Wagner, Ph.D.
Vice President, Kantar Health


  • Breast Cancer
    Discussion of recent data and market impact associated with development in hormone
    receptor-positive breast cancer
  • Melanoma
    A review of pivotal new data for BRAF inhibitors and PD-1/PD-L1 inhibitors and a discussion of the future evolution of treatment in this disease
  • Non-Small Cell Lung Cancer (NSCLC)
    A discussion of recent developments in relapsed/refractory disease (Cyramza, necitumumab, pembrolizumab) and next-generation inhibitors in biomarker subpopulations (EGFR, ALK)
  • Immunotherapy
    Discussion of new data for PD-1/PD-L1 inhibitors and other immunotherapeutics in development, with a review of development strategies
  • Chronic Lymphocytic Leukemia
    Discussion of recent pivotal data (Imbruvica, idelalisib, Arzerra, Gazyva) and the rapidly changing standard of care in this disease
 Click here for more information and to download the registration form.

Note: The presentation will start at 10:00 am. We will allow for Q&A following the presentations. This event will be followed by a networking event with refreshments.


Latest News

  • Kantar Health Wins WPPed Cream Award

    Sep 20, 2016

    Read More

  • Kantar unveils a new corporate identity across its operating brands, announces launch of two new operating brands

    Sep 9, 2016

    Read More

  • Majority of Type 2 Diabetes Patients in Japan Are Not Overweight

    Sep 6, 2016

    Read More